rlsciences.com

What It Is

Real Life Sciences (RLS) is a professional services and SaaS provider focused on clinical trial data disclosure and transparency scenarios. Its focus is not general-purpose document editing, but rather helping organizations reduce privacy and trade-secret risks when sharing data with regulators, partners, internal teams, or publication channels—especially around clinical trial documents, personal information, and confidential information protection.

Core Features

The core product identified in the source material is RLS Protect, positioned as an AI-driven clinical trial anonymization and redaction tool. It is designed to accelerate the classification, anonymization, and redaction of personal data and confidential information. It also includes trial transparency project management solutions, providing management capabilities for transparency disclosure projects. RLS states that its tools have been used to process thousands of documents and more than 1 million pages of content, and claims to be 25%-50% faster than standard editing tools such as Adobe.

Pricing and Deployment

The available material does not disclose plans, pricing, subscription terms, usage-based billing, or enterprise quote details. There is also no visible information about a free version or trial. On deployment, it is only clearly described as SaaS, with no indication of whether private deployment, self-hosting, or hybrid deployment is supported. Payment methods are not publicly listed either, so procurement will most likely require contacting sales for confirmation.

Compliance, Security, and Collaboration

RLS’s core value proposition is protecting Personal & Confidential Information, and it supports organizations responding to regulatory changes involving Health Canada, EMA Clinical Trial Regulation, CTIS, and similar frameworks. The material suggests it is suitable for teams responsible for transparency and disclosure work. However, specific security certifications, data residency options, encryption details, audit logs, permission models, third-party integrations, and API capabilities are not reflected in the available content.

Pros, Cons, and Best Fit

Its strengths are its clear industry focus and vertical solution around clinical trial disclosure, anonymization, and project management. It is a good fit for pharmaceutical companies, CROs, clinical operations teams, regulatory affairs teams, and transparency disclosure teams. The main limitation is the lack of public detail, especially around pricing, technical integrations, permissions, security certifications, and deployment options. Further sales inquiry and security review are needed before evaluation or procurement.

Access from China

Access from mainland China is unknown. For domestic pharmaceutical companies or CROs considering adoption, key points to verify include website and SaaS connectivity, cross-border data transfer compliance, payment methods, data hosting regions, and whether there are local alternatives for document anonymization, pharmaceutical compliance disclosure, or data security governance.